Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen Receptor Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01421472
What this trial is testing

A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Who this might be right for
ER Positive, Her2 Negative Breast Cancer PatientsTriple Negative Breast Cancer Patients
Merrimack Pharmaceuticals 196
Testing effectiveness (Phase 2)Looking for participantsNCT04802759
What this trial is testing

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Who this might be right for
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
Hoffmann-La Roche 316
Not applicableStudy completedNCT00911716
What this trial is testing

TC Avastin. ICORG 08-10, V6

Who this might be right for
Breast Cancer
Cancer Trials Ireland 106
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT00070564
What this trial is testing

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 3,294
Not applicableActive Not RecruitingNCT02515110
What this trial is testing

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Who this might be right for
Breast CancerNode-positive Breast CancerBreast Adenocarcinoma+2 more
Virginia Commonwealth University 137
Testing effectiveness (Phase 2)Study completedNCT02970682
What this trial is testing

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Evgen Pharma 60
Not applicableStudy completedNCT01582074
What this trial is testing

The Ultrasound Study of Tamoxifen

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 247
Early research (Phase 1)Ended earlyNCT01208441
What this trial is testing

RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT02219789
What this trial is testing

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+3 more
Mayo Clinic 10
Early research (Phase 1)Active Not RecruitingNCT04052555
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaHER2-Negative Breast CarcinomaLocalized Breast Carcinoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07275463
What this trial is testing

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 40
Not applicableStudy completedNCT02625935
What this trial is testing

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Who this might be right for
Breast Cancer
NanoString Technologies, Inc. 206
Large-scale testing (Phase 3)Study completedNCT02422615
What this trial is testing

Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 726
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Not applicableLooking for participantsNCT04660435
What this trial is testing

To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

Who this might be right for
Metastatic Breast CancerER Positive Breast CancerHER2-negative Breast Cancer
Fondazione Sandro Pitigliani 150
Large-scale testing (Phase 3)Study completedNCT00044291
What this trial is testing

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-dependent
Intarcia Therapeutics 865
Testing effectiveness (Phase 2)Study completedNCT01605396
What this trial is testing

A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 80
Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT01194440
What this trial is testing

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Who this might be right for
Ductal Carcinoma in SituEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Next Page